PhDs in Focus: Understanding rare diseases Posted: Thursday, November 7, 2024 Author: Aoife O’Sullivan For our PhDs in Focus blog series, Aoife O’Sullivan outlines how their Manchester BRC PhD project is investigating how certain rare developmental genetic conditions affect a person’s thinking, behavioural, emotional and social skills, as part of the Rare Conditions theme. Continue reading full article: PhDs in Focus: Understanding rare diseases
Embed, Build, Accelerate – Manchester BRC Director’s blog – November 2024 Posted: Friday, November 1, 2024 Author: Professor Anne Barton In her latest blog Professor Anne Barton, Director of Manchester BRC, celebrates the £68.2 million in additional funding awards that we have leveraged in our second year and how they support our vast teams to deliver research which can save, change and improve lives. Continue reading full article: Embed, Build, Accelerate – Manchester BRC Director’s blog – November 2024
PhDs in Focus: The predictive value of extended high-frequency hearing Posted: Thursday, October 31, 2024 Author: Melanie Lough For our PhDs in Focus blog series, Melanie Lough outlines how their Manchester BRC PhD project aims to determine the value of the highest frequency range of human hearing for predicting hearing aid fitting outcomes, as part of our Hearing Health theme. Continue reading full article: PhDs in Focus: The predictive value of extended high-frequency hearing
Most non-cancer pain opioid prescriptions are for musculoskeletal conditions, study finds Posted: Monday, October 28, 2024 Nearly three quarters of new non-cancer pain opioid prescriptions were for patients with musculoskeletal conditions, despite limited evidence of the drug’s efficacy, according to the largest UK study of its kind. Continue reading full article: Most non-cancer pain opioid prescriptions are for musculoskeletal conditions, study finds
PhDs in Focus: Understanding the risk of developing mental health conditions among children and young people after a cancer diagnosis Posted: Wednesday, October 9, 2024 Author: Moe Zandy For our PhDs in Focus blog series, Moe Zandy outlines how their Manchester BRC PhD project is investigating the risk of developing mental health conditions among children and young people who have been diagnosed with cancer, as part of the Living With and Beyond Cancer theme. Continue reading full article: PhDs in Focus: Understanding the risk of developing mental health conditions among children and young people after a cancer diagnosis
PhDs in Focus: Enhancing opioid safety – Predicting adverse outcomes in musculoskeletal and post-surgery patients Posted: Wednesday, October 9, 2024 Author: Christina Diomatari For our PhDs in Focus blog series, Christina Diomatari outlines how their Manchester BRC PhD project aims to improve the safety of opioid use for patients with musculoskeletal conditions and those recovering from orthopaedic surgery, as part of the Rheumatic and Musculoskeletal Diseases theme. Continue reading full article: PhDs in Focus: Enhancing opioid safety – Predicting adverse outcomes in musculoskeletal and post-surgery patients
PhDs in Focus: Treatment decision-making in a complex cancer setting Posted: Wednesday, October 9, 2024 Author: Katie Dixon For our PhDs in Focus blog series, Katie Dixon shares how their Manchester BRC PhD project focuses on the development of an intervention aimed at helping people make informed decisions about small-cell lung cancer treatment, as part of the Cancer Advanced Radiotherapy theme. Continue reading full article: PhDs in Focus: Treatment decision-making in a complex cancer setting
Manchester researchers identify system that can detect more breast cancer patients eligible for testing for cancer risk genes Posted: Monday, October 7, 2024 A Manchester BRC-funded study has shown that a simple system, called the Manchester Score, can identify more breast cancer patients who are eligible for testing for inherited faulty genes that can cause breast cancer. Continue reading full article: Manchester researchers identify system that can detect more breast cancer patients eligible for testing for cancer risk genes